StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | EXEL Exelixis | $50.17 | +1.05% | $12.6B | 15.1 | 5.3 | +7.9% | 96.4% | 45 |
| 1 | MRNA Moderna | $46.89 | -0.78% | $18.6B | — | 8.4 | -30.0% | 35.0% | 51 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $74.97 |
| -0.75% |
| $10.6B |
| — |
| 17.0 |
| +14.1% |
| — |
| 40 |
| 3 | NBIX Neurocrine Biosciences | $156.72 | +0.78% | $15.8B | 23.6 | 5.1 | +28.6% | 98.2% | 39 |
| 4 | BMRN BioMarin Pharmaceutical | $54.11 | +0.02% | $10.4B | 38.8 | 3.2 | +9.9% | 80.2% | 39 |
| 5 | IONS Ionis Pharmaceuticals | $75.58 | -0.26% | $12.5B | — | 11.8 | +47.4% | 98.3% | 37 |
| 6 | MDGL Madrigal Pharmaceuticals | $517.28 | +0.72% | $11.9B | — | 10.5 | +256.8% | 93.1% | 33 |
| 7 | INCY Incyte | $97.18 | -0.24% | $19.4B | 13.6 | 3.6 | +21.5% | 93.0% | 30 |
| 8 | BBIO BBIO | $69.14 | -1.62% | $13.5B | — | 23.3 | +355.2% | 95.1% | — |
| 9 | SMMT SMMT | $16.63 | -4.81% | $12.9B | — | 13437.3 | — | — | — |